Dr. Quenten Schwarz is a developmental neuroscientist heading the Neurovascular Research Laboratory at the Centre for Cancer Biology. Following a PhD in Human Genetics obtained from the Univresity of Adelaide he relocated to London to undertake Postdoctoral training at University College London. In this time he investigated the molecular control of neuronal and vascular development. Since returning to Australia to establish his laboratory in 2010 he has been awarded several NHMRC project grants, an NHMRC CDA Fellowship and is a current National Heart Foundation Future Leader Fellow. His work is primarily focused on understanding how interactions between neural crest cells, neurons and endothelial cells control morphogenesis of embryonic... Read more
About me
Dr. Quenten Schwarz is a developmental neuroscientist heading the Neurovascular Research Laboratory at the Centre for Cancer Biology. Following a PhD in Human Genetics obtained from the Univresity of Adelaide he relocated to London to undertake Postdoctoral training at University College London. In this time he investigated the molecular control of neuronal and vascular development. Since returning to Australia to establish his laboratory in 2010 he has been awarded several NHMRC project grants, an NHMRC CDA Fellowship and is a current National Heart Foundation Future Leader Fellow. His work is primarily focused on understanding how interactions between neural crest cells, neurons and endothelial cells control morphogenesis of embryonic structures including the craniofacial skeleton, heart and brain. In the past 5 years he has 24 publications in high-impacting journals, including 14 as first or senior author. In recognition of his achievements he has been honoured with several prestigious awards, including the 2011 South Australia Bioinnovation Award, the 2014 AW Campbell Award by the Australasian Neuroscience Society for early career research excellence, and the 2015 South Australian ASMR Leading Light Award.
About me
Doctor of Philosophy (Molecular Biosciences) The University of South Australia
Research
Excludes commercial-in-confidence projects.
Identification and assessment of new treatment options for the childhood cancer medulloblastoma, Neurosurgical Research Foundation, 02/01/2024 - 31/12/2026
Targeting sphingosine kinase 1 as a novel therapeutic strategy in childhood medulloblastoma, Neurosurgical Research Foundation, 01/10/2024 - 30/09/2025
Exploring aberrant chondrocyte death as a new origin of craniofacial defects, Australian Cranio-Maxillo Facial Foundation, 01/10/2024 - 30/09/2025
Exploring pathogenicity of novel PPIL1 variants in microcephaly, Medical Research Future Fund, 30/06/2023 - 31/07/2024
Defining the role of IGF-1 as a novel angiocrine factor in the development and treament of common craniofacial disorders, NHMRC - Project Grant, 01/01/2018 - 31/12/2021
Novel roles for neural crest cells in cardiac morphogenesis, NHMRC - Project Grant, 01/01/2019 - 31/12/2021
Identifying the role of Nedd4 in common neurocristopathies such as craniofacial disorders and cardiac outflow tract defects, Central Adelaide Local Health Network Incorporated, 01/01/2018 - 31/12/2020
Novel mechanisms integrating the central and autonomic nervous system, ARC - Discovery Projects, 01/01/2018 - 31/12/2020
Investigation of the role of PI3-kinase in the regulation of angiogenesis, NHMRC - Project Grant, 01/01/2016 - 31/12/2019
Defining the mechanisms controlling cardiac outflow tract formation, NHF-Future Leader Fellowship, 01/01/2016 - 31/12/2019
Investigating the role of 14-3-3ζ in medulloblastoma, Neurosurgical Research Foundation, 01/01/2018 - 31/03/2019
Defining the role of VEGF and vascular formation in craniofacial development, NHMRC - Project Grant, 01/01/2014 - 31/12/2017
The molecular control of neural crest cell development, NHMRC - Project Grant, 01/01/2014 - 31/12/2016
Research
Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included. To see earlier years visit ORCID or Scopus
Open access indicates that an output is open access.
Year | Output |
---|---|
2022 |
1
|
2013 |
6
|
2008 |
|
Year | Output |
---|---|
2024 |
Open access
3
|
2023 |
Open access
4
4
2
|
2023 |
Open access
6
6
3
|
2023 |
Open access
|
2023 |
Open access
28
29
123
|
2023 |
Open access
2
2
2
|
2022 |
Open access
4
4
7
|
2022 |
Open access
2
2
11
|
2021 |
Open access
6
5
1
|
2021 |
Open access
9
8
7
|
2021 |
Open access
54
52
3
|
2020 |
Open access
14
13
13
|
2020 |
Open access
6
5
8
|
2019 |
2
|
2019 |
Open access
12
11
1
|
2019 |
Open access
17
15
80
|
2018 |
Open access
22
19
4
|
2017 |
Open access
14
13
8
|
2017 |
Open access
19
19
2
|
2016 |
Open access
28
21
1
|
2016 |
Open access
19
18
1
|
2016 |
Open access
30
29
13
|
2016 |
Open access
21
21
|
2015 |
Open access
1
|
2015 |
Open access
30
30
6
|
2015 |
13
12
2
|
2015 |
Open access
46
43
6
|
2015 |
Open access
49
47
13
|
2015 |
1
4
1
|
2015 |
Open access
37
35
1
|
2014 |
Open access
41
39
10
|
2014 |
Open access
59
56
|
2014 |
Open access
20
19
|
2014 |
Open access
2
4
1
|
2014 |
Open access
93
92
1
|
2013 |
Open access
27
26
|
2013 |
Open access
24
27
|
2013 |
5
4
|
2012 |
Open access
92
88
|
2012 |
Open access
75
72
|
2012 |
Open access
63
61
|
2011 |
Open access
67
63
|
2011 |
Open access
140
128
|
2011 |
Open access
95
81
|
2011 |
Open access
60
60
|
2010 |
Open access
885
814
|
2010 |
Open access
32
31
|
2010 |
Open access
76
65
|
2010 |
Open access
28
27
|
2009 |
Open access
51
45
|
2009 |
Open access
95
89
|
2008 |
Open access
150
140
|
2008 |
Open access
87
79
|
2008 |
85
75
|
2008 |
Open access
54
48
|
Research
Details | Registry | Status |
---|---|---|
Lopez, Angel; Schwarz, Quenten |
Australia | Filed |
Schwarz, Quenten; Lopez, Angel |
Australia | Filed |
External engagement & recognition
Organisation | Country |
---|---|
Australian Catholic University | AUSTRALIA |
Australian Craniofacial Unit | AUSTRALIA |
Case Western Reserve University | UNITED STATES |
Claude Bernard Lyon University 1 | FRANCE |
CSIRO Australia (Commonwealth Scientific Industrial Research organisation) | AUSTRALIA |
Drexel University | UNITED STATES |
Eötvös Loránd University | HUNGARY |
European Molecular Biology Laboratory | GERMANY |
Flinders University | AUSTRALIA |
Garvan Institute of Medical Research | AUSTRALIA |
Harry Perkins Institute of Medical Research | AUSTRALIA |
Hebrew University of Jerusalem | ISRAEL |
Heidelberg University | GERMANY |
Imperial College of Science, Technology and Medicine | UNITED KINGDOM |
Institute of Medical & Veterinary Science, SA Pathology | AUSTRALIA |
Institute of Medical and Veterinary Science | AUSTRALIA |
Karolinska Institute | SWEDEN |
KTH Royal Institute of Technology | SWEDEN |
La Trobe University | AUSTRALIA |
Magyar Tudomanyos Akademia | HUNGARY |
Max Planck Institute for Biology of Ageing | GERMANY |
Max Planck Institute of Experimental Medicine | GERMANY |
Medical University of Vienna | AUSTRIA |
Mental Health Research Institute of Victoria | AUSTRALIA |
Monash University | AUSTRALIA |
Mondor Institute of Biomedical Research | FRANCE |
Murdoch Childrens Research Institute | AUSTRALIA |
Nagoya University | JAPAN |
Peter MacCallum Cancer Centre | AUSTRALIA |
Prince Henry's Institute of Medical Research | AUSTRALIA |
QIMR Berghofer Medical Research Institute | AUSTRALIA |
Reed College | UNITED STATES |
RMIT University | AUSTRALIA |
Royal Adelaide Hospital | AUSTRALIA |
SA Pathology | AUSTRALIA |
San Raffaele Scientific Institute | ITALY |
Technion Israel Institute of Technology | ISRAEL |
UCL | UNITED KINGDOM |
UCL Institute of Ophthalmology | UNITED KINGDOM |
UCSF School of Medicine | UNITED STATES |
University College London | UNITED KINGDOM |
University of Aberdeen | UNITED KINGDOM |
University of Adelaide | AUSTRALIA |
University of Auckland | NEW ZEALAND |
University of California | UNITED STATES |
University of Cambridge | UNITED KINGDOM |
University of Chile | CHILE |
University of Edinburgh | UNITED KINGDOM |
University of Geneva | SWITZERLAND |
University of Illinois at Urbana-Champaign | UNITED STATES |
University of London | UNITED KINGDOM |
University of Melbourne | AUSTRALIA |
University of Milan | ITALY |
University of Padova | ITALY |
University of Queensland | AUSTRALIA |
University of South Australia | AUSTRALIA |
University of Southern California | UNITED STATES |
University of Sydney | AUSTRALIA |
Victor Chang Cardiac Research Institute | AUSTRALIA |
Walter and Eliza Hall Institute of Medical Research | AUSTRALIA |
Women's and Children's Hospital | AUSTRALIA |
Yale University | UNITED STATES |
External engagement & recognition
Engagement/recognition | Year |
---|---|
Editorial Board MemberJournal of Developmental Biology |
2023 |
Editorial Board MemberScientific Reports (Nature Publishing Group) |
2023 |
Editorial Board MemberJournal of Developmental Biology |
2022 |
Editorial Board MemberScientific Reports (Nature Publishing Group) |
2022 |
Invited speakerSociety for Developmental Biology in Singapore, Singapore |
2022 |
Editorial Board MemberScientific Reports (Nature Publishing Group) |
2021 |
Editorial Board MemberJournal of Developmental Biology |
2021 |
Editorial Board MemberScientific Reports (Nature Publishing Group) |
2020 |
Editorial Board MemberJournal of Developmental Biology |
2020 |
Editorial Board MemberScientific Reports (Nature Publishing Group) |
2019 |
Invited speakerGordon Research Conference on Insulin and IGF signalling, California, USA |
2019 |
Keynote SpeakerNeuroblastoma UK, Cambridge, UK |
2019 |
Keynote SpeakerRoyal Australian College of Surgeons Annual Scientific Congress, Bangkok, Thailand |
2019 |
Editorial Board MemberScientific Reports (Nature Publishing Group) |
2018 |
Editorial Board MemberScientific Reports (Nature Publishing Group) |
2018 |
Invited speakerKloster Seeon Meeting Angiogenesis, Seeon, Germany |
2018 |
Plenary speakerOmnibus Genetic Strategy for Cancer and Neurodevelopment Disorder, Nagoya, Japan |
2018 |
Editorial Board MemberScientific Reports (Nature Publishing Group) |
2017 |
Editorial Board MemberScientific Reports (Nature Publishing Group) |
2017 |
Future Leader FellowNational Heart Foundation |
2017 |
Keynote Speaker5th International Symposium onn Phaeochromocytoma and Paraganglioma, Sydney, Australia |
2017 |
Editorial Board MemberScientific Reports (Nature Publishing Group) |
2016 |
Editorial Board MemberScientific Reports (Nature Publishing Group) |
2016 |
Future Leader FellowNational Heart Foundation |
2016 |
Leading Light AwardAustralian Society for Medical Research (ASMR), South Australian Division |
2015 |
A.W. Campbell AwardAustralasian Neuroscience Society |
2014 |
Invited speaker11th World Congress of Society for Brain Mappring and Therapeutics, Sydney, Australia |
2014 |
Keynote Speaker10th Asia Pacific Craniofacial Conference, Adelaide, Australia |
2014 |
Keynote SpeakerNeurofair, Univresity Putra, Malaysia |
2013 |
Plenary speaker4th Developmental Biology Meeting, Brisbane, Australia |
2013 |
Plenary speakerHuman Genetics Society of Australia Annual Symposium, Adelaide, Australia |
2013 |
Young Achiever AwardBioinnovation SA |
2011 |
Teaching & student supervision
Supervisions from 2010 shown
Thesis title | Student status |
---|---|
110391 - Oncogenic drivers of neuroblastoma | Current |
Defining the origin of schizophrenia like defects arising from 14-3-3 zeta deficiency. | Current |
Investigating Extracellular Matrix in Cardiac Outflow Tract Development | Current |
Investigating the role of endothelial derived IGF1 in epidermal development and disease | Current |
A novel role for 14-3-3zeta in coordinating interneuron development through regulation of Rac1 and non-canonical Shh signalling | Completed |
Investigating the role of NEDD4 in neural crest cell development and craniofacial bone formation | Completed |
PRDM5: an essential regulator of craniofacial development | Completed |